
by Fatemeh Rahmatabadi: This week’s journal club focuses on a study from Drugs in R&D (2024) aiming to assess the activity of trametinib against a panel of tumor cells from patients with AML
1/13/2026 Agnes
1/20/2026 Shayla
1/27/2026 Lucas
2/3/2026 Ulrik
2/10/2026 Olena
2/17/2026 Kayko
3/3/2026 Fatemeh